Issues in the adjunct therapy of severe sepsis (original) (raw)

Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach

Didier De La Garanderie

The Lancet Infectious Diseases, 2013

View PDFchevron_right

Immunotherapy of sepsis: flawed concept or faulty implementation?

Steven Opal

Vaccine, 1999

View PDFchevron_right

New Therapies for Sepsis

Simon Nadel

Current Topics in Medicinal Chemistry, 2008

View PDFchevron_right

Immunotherapy for Sepsis — A New Approach against an Ancient Foe

Steven Opal

New England Journal of Medicine, 2010

View PDFchevron_right

Impact of Immunomodulating Therapy on Morbidity in Patients with Severe Sepsis

Chris Barker

American Journal of Respiratory and Critical Care Medicine, 1999

View PDFchevron_right

Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?

Peter Pickkers

American Journal of Respiratory and Critical Care Medicine, 2013

View PDFchevron_right

Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?

Miroslav Prucha

Archivum Immunologiae et Therapiae Experimentalis

View PDFchevron_right

Mechanisms of sepsis and insights from clinical trials

Anthony Suffredini

Drug discovery today. Disease mechanisms, 2007

View PDFchevron_right

Mechanisms of immunodysregulation in sepsis

Catherine Fitting

Contributions to nephrology, 2004

View PDFchevron_right

Sepsis Immunopathology: Perspectives of Monitoring and Modulation of the Immune Disturbances

Tom Skirecki

View PDFchevron_right

Accepted for publication on September 14, 2007. SEPSIS: FROM BENCH TO BEDSIDE

Luiz Francisco

2014

View PDFchevron_right

Sepsis and Septic Shock: Updates

Amber Sabeen

2015

View PDFchevron_right

New Strategies for Treatment of Sepsis

Alberto Tosoni

Medicina

View PDFchevron_right

Sepsis and Septic Shock: Current Treatment Strategies and New Approaches

AYSE GiZEM POLAT

The Eurasian Journal of Medicine, 2017

View PDFchevron_right

Management of Severe Sepsis and Septic Shock: Challenges and Recommendations

Nicola Bianco

Critical Care Clinics, 2006

View PDFchevron_right

Potentia Hazards of Combination Immunotherapy in the Treatment of Experimental Septic Shock

Alan Cross

Journal of Infectious Diseases, 1996

View PDFchevron_right

Anti-tumor necrosis factor α F(ab')2 antibody fragments protect in murine polymicrobial sepsis: Concentration and early intervention are fundamental to the outcome

Rafael Bojalil

Inflammation Research, 2006

View PDFchevron_right

Understanding sepsis-induced immunosuppression and organ dysfunctions: from immunosuppression to immunotherapy

Tejprakash Sinha

Exploration of Immunology

View PDFchevron_right

Pharmacological treatment of sepsis

Armand Girbes

Fundamental & Clinical Pharmacology, 2008

View PDFchevron_right

Adjunctive therapies for severe sepsis

Xavier Wittebole

International Journal of Antimicrobial Agents, 2008

View PDFchevron_right

The role of tumor necrosis factor in sepsis

Louis Saravolatz

Clinical immunology and immunopathology, 1992

View PDFchevron_right

Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure

dale osborne

JAMA, 2011

View PDFchevron_right

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

Didier De La Garanderie

Nature Reviews Immunology, 2013

View PDFchevron_right

Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies

Anne-claire Lukaszewicz

Current Opinion in Immunology, 2013

View PDFchevron_right

New treatment strategies for severe sepsis and septic shock

David Gurka

Current Opinion in Critical Care, 2003

View PDFchevron_right

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

Steven Berman, Richard Wunderink

Journal of Cardiothoracic and Vascular Anesthesia, 1998

View PDFchevron_right

Management of Sepsis: Recent Advancement

Dr. Zabed Jillul Bari

Journal of Bangladesh College of Physicians and Surgeons, 2017

View PDFchevron_right

Proinflammatory versus anti-inflammatory response in sepsis patients: looking at the cytokines

Sumit Ray

Critical Care, 2014

View PDFchevron_right

Can the Reduction of Cytokines Stop the Progression of Sepsis?

Mehmet Dokur

Cureus

View PDFchevron_right

Inhibition of Macrophage-activating Cytokines is Beneficial in the Acute Septic Response

Henry Redmond

Annals of Surgery, 1991

View PDFchevron_right

Immunopathologic responses to non-lethal sepsis

Samuel Ebong

1999

View PDFchevron_right

Critical advances in septicemia and septic shock

Undurti Das

Critical care (London, England), 2000

View PDFchevron_right

Dosage and Timing of Anti-TNF-α Antibody Treatment Determine Its Effect on Resistance to Sepsis after Injury

Richard Molloy

Journal of Surgical Research, 1996

View PDFchevron_right

Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock

Philippe Vandekerckhove

European Journal of Clinical Investigation, 1991

View PDFchevron_right

Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis

Alan Cross

Journal of Clinical Investigation, 1991

View PDFchevron_right